Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02477319 · ClinicalTrials.gov registry record
A Two-Part Multicenter Prospective Longitudinal Study of CFTR-dependent Disease Profiling in Cystic Fibrosis (PROSPECT)
A clinical trial of Cystic Fibrosis, sponsored by University of Alabama at Birmingham.
- Completed
- Registry status
- 452
- Enrollment target
- 20
- Study locations
NCT02477319 is a study of Cystic Fibrosis that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 452 participants, above the 177-participant average among 169 other Cystic Fibrosis trials with a reported enrollment target (155% higher). The trial reports 20 study locations across 13 states.
The verdict
NCT02477319, a study of Cystic Fibrosis, has completed, sponsored by University of Alabama at Birmingham.
- COMPLETED
- Registry status
- 452 participants
- Enrollment target
- 20
- Study locations
Study Summary
identify and validate biomarkers that might reflect partial restoration of CFTR function and can be used to monitor disease progression, and ii) evaluate the mechanistic effects of CFTR modulators and other relevant therapies in individuals with CF
Conditions Studied
Interventions
- OTHER Observational
Study Locations (20)
Missouri
- Children's Mercy Hospital - Kansas City
- Cardinal Glennon Children's Medical Center - St Louis
- St. Louis Children's Hospital - St Louis
California
- Childrens Hospital Los Angeles - Los Angeles
- Lucile S. Packard Children's Hospital - Palo Alto
Colorado
- The Children's Hospital Colarado - Aurora
- National Jewish Health - Denver
Massachusetts
- Massachusetts General Hospital - Boston
- Children's Hospital Boston - Boston
Michigan
- Children's Hospital of Michigan - Detroit
- Devon Children's Hospital at Spectrum Health - Grand Rapids
New York
- Women and Children's Hospital of Buffalo - Buffalo
- Columbia University Medical Center - New York
Alabama
- University of Alabama at Birmingham - Birmingham
Illinois
- Ann & Robert H. Lurie Children's Hospital of Chicago - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 452 participants |
| Start Date | 2015-03 |
| Est. Completion | 2018-07-27 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02477319
The ClinicalTrials.gov registry entry for NCT02477319 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 452 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 177-participant average among 169 other Cystic Fibrosis trials with a reported enrollment target (155% higher). The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Cystic Fibrosis appearing as the primary indexed condition, and to 1 intervention - of which Observational is the first listed.
NCT02477319 reports 20 study locations spanning 13 distinct geographic areas - top geographies include Missouri, California, Colorado.
Frequently Asked Questions
What is clinical trial NCT02477319 about?
NCT02477319 is a clinical study titled "A Two-Part Multicenter Prospective Longitudinal Study of CFTR-dependent Disease Profiling in Cystic Fibrosis (PROSPECT)". identify and validate biomarkers that might reflect partial restoration of CFTR function and can be used to monitor disease progression, and ii) evaluate the mechanistic effects of CFTR modulators and other relevant therapies in individuals with CF
What is the current status of trial NCT02477319?
This trial is currently completed. The enrollment target is 452 participants. The study started on 2015-03. Estimated completion is 2018-07-27.
What conditions does trial NCT02477319 study?
This clinical trial studies the following conditions: Cystic Fibrosis.
What interventions are being tested in trial NCT02477319?
The interventions under investigation include: Observational (OTHER).
Who is sponsoring clinical trial NCT02477319?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02477319 being conducted?
This trial has 20 study locations across Alabama, California, Colorado, Illinois, Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cystic Fibrosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Exercise in Child Health
RECRUITING · NA
-
Targeting Inflammation With Losartan to Improve Response to Modulator Therapy in Cystic Fibrosis.
RECRUITING · Phase 2
-
A Pilot and Feasibility Study to Evaluate High vs Low Glycemic Index Mixed Meal Tolerance Test in Adolescents and Young Adults With Cystic Fibrosis
RECRUITING · NA
-
A Research Study to Advance the CF Therapeutics Pipeline for People Without Modulators
RECRUITING
-
Assessing Tenapanor as a Treatment of CF-related Constipation.
RECRUITING · Phase 3
-
Genetics of Insulin and Incretins in Cystic Fibrosis
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.